FDA Reviews RSV Treatments for Infants

Reading

Read this text and listen to it at the same time. If you don’t know a word click it to see explanation, hear pronunciation or add it to vocabulary.

The FDA is reviewing two drugs that protect babies from RSV. This virus sends many young children to the hospital each year.

These drugs are not vaccines, but they are like natural antibodies. Government officials are also changing childhood vaccine advice.

The drug companies, Merck and Sanofi, say their drugs are safe. They have found no new problems with their approved medications.

These drugs are special antibodies that help fight the RSV virus. RSV is a big threat for very young children and the elderly.

This safety review comes during other changes at health agencies. New health leaders are looking closely at current medical guidelines.

Answer the questions to the text. Speak or write, you choose. AI will assess your answers.

What is the FDA reviewing?

The FDA is reviewing two drugs that protect babies from RSV.

Are the drugs vaccines?

No, these drugs are not vaccines, but they are like natural antibodies.

Which companies are making the drugs?

The drug companies are Merck and Sanofi.

Look at the article image and describe what you see on it. You may either speak or write your answer there.

Discuss this article with your AI tutor to practice. Your tutor will help you with vocabulary and grammar.

Read a new article every day and
discuss it with AI at lingolette.com